OKYO Pharma Ltd ADR (OKYO) — Strategic Asset Allocation Index
OKYO Pharma Ltd ADR (OKYO) has a Strategic Asset Allocation Index of 0.1% as of March 2022. Strategic assets (PP&E of $3.98K plus long-term investments of $-) total $3.98K, measured against net assets of $2.95 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check OKYO cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
OKYO Pharma Ltd ADR Strategic Asset Allocation Index (2019–2022)
This chart shows how OKYO Pharma Ltd ADR's Strategic Asset Allocation Index has evolved across 3 annual periods from 2019 to 2022. As of March 2022, the index stands at 0.1%, representing strategic assets of $3.98K against net assets of $2.95 Million USD. See OKYO Pharma Ltd ADR leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for OKYO Pharma Ltd ADR (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for OKYO Pharma Ltd ADR from 2019 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of OKYO Pharma Ltd ADR.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.1% | $3.98K | $3.98K | $- | $2.95 Million | ▼ -1.3 pp |
| 2021 | 1.4% | $75.81K | $75.81K | $- | $5.32 Million | ▲ +1.2 pp |
| 2019 | 0.3% | $847.00 | $847.00 | $- | $333.14K | — |